With the latest FDA guidelines, new product development is pretty limited for most in the industry. But, no cash for years makes any form of measurable growth unlikely. As for Dan, he's Strong's bitch until further notice and likely by design...new shares can't be issued, AS exceeded, almost all to Strong. Dan will do as told, whether he likes it or not.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.